glp-1 shots vs pills Half of users ditch their injections — and some are turning to other weight-loss methods instead 5 Things to Know Before

Notably, Eli Lilly and Company received FDA approval in November 2023 for Zepbound, a chronic weight management medication for adults with obesity-related health conditions

Clinical evidence shows that personalized dosing based on genetic testingsuch as PlexusDx Precision Peptide analysisoften produces faster 20-pound achievement than standard dosing protocols alone

We also report that 13% of patients with type 1 diabetes in our registry use adjuvant glucose-lowering therapy in addition to insulin, significantly higher than the 5.4% reported from the T1D Exchange Registry in the US [18]

Like GH, low levels of IGF-1 are associated with low energy and mood